Armenian et al identified risk factors for late congestive heart failure (CHF) in patients who have received a hematopoietic cell transplant (HCT). The authors are from Childrens' Hospital Los Angeles, University of Southern California in Los Angeles, City of Hope National Medical Center and the University of Minnesota.